875 A SHORTER TIME TO PROSTATE-SPECIFIC ANTIGEN NADIR FOLLOWING ANDROGEN SUPPRESSION THERAPY PREDICTS POORER SURVIVAL IN PROSTATE CANCER PATIENTS

A. Gagnat; O. Celhay; C. Pirès; G. Fromont; B. Doré; J. Irani

doi:10.1016/s1569-9056(10)60857-3

875 A SHORTER TIME TO PROSTATE-SPECIFIC ANTIGEN NADIR FOLLOWING ANDROGEN SUPPRESSION THERAPY PREDICTS POORER SURVIVAL IN PROSTATE CANCER PATIENTS

European Urology Supplements ◽

10.1016/s1569-9056(10)60857-3 ◽

2010 ◽

Vol 9 (2) ◽

pp. 276-277

Author(s):

A. Gagnat ◽

O. Celhay ◽

C. Pirès ◽

G. Fromont ◽

B. Doré ◽

...

Keyword(s):

Prostate Cancer ◽

Cancer Patients ◽

Prostate Specific Antigen ◽

Specific Antigen ◽

Androgen Suppression

Download Full-text

Nadir Prostate-Specific Antigen After Neoadjuvant Androgen Suppression (AS) in Prostate Cancer Patients Receiving Short-term AS and Radiation Therapy: Pooled Analysis of Four NRG Oncology/RTOG Randomized Clinical Trials

International Journal of Radiation Oncology*Biology*Physics ◽

10.1016/j.ijrobp.2015.07.111 ◽

2015 ◽

Vol 93 (3) ◽

pp. S46

Author(s):

C.L. Hallemeier ◽

P. Zhang ◽

T.M. Pisansky ◽

G.E. Hanks ◽

D.G. McGowan ◽

...

Keyword(s):

Prostate Cancer ◽

Clinical Trials ◽

Radiation Therapy ◽

Cancer Patients ◽

Prostate Specific Antigen ◽

Randomized Clinical Trials ◽

Specific Antigen ◽

Pooled Analysis ◽

Short Term ◽

Androgen Suppression

Download Full-text

The change in free-to-total prostate-specific antigen during progression to androgen-independent state in prostate cancer patients: utilization for intermittent androgen suppression therapy

Prostate Cancer and Prostatic Diseases ◽

10.1038/sj.pcan.4500328 ◽

1999 ◽

Vol 2 (S3) ◽

pp. S2-S2

Author(s):

K Akakura

Keyword(s):

Prostate Cancer ◽

Cancer Patients ◽

Prostate Specific Antigen ◽

Specific Antigen ◽

Independent State ◽

Total Prostate Specific Antigen ◽

Intermittent Androgen Suppression ◽

Androgen Suppression ◽

Androgen Independent

Download Full-text

Measurements of tissue polypeptide-specific antigen and prostate-specific antigen in prostate cancer patients under intermittent androgen suppression therapy

British Journal of Cancer ◽

10.1038/bjc.1997.259 ◽

1997 ◽

Vol 75 (10) ◽

pp. 1515-1518 ◽

Cited By ~ 12

Author(s):

G Theyer ◽

S Holub ◽

A Dürer ◽

S Andert ◽

I Haberl ◽

...

Keyword(s):

Prostate Cancer ◽

Cancer Patients ◽

Prostate Specific Antigen ◽

Specific Antigen ◽

Intermittent Androgen Suppression ◽

Androgen Suppression

Download Full-text

Detection of N,N-diacetyllactosamine (LacdiNAc) containing free prostate-specific antigen for early stage prostate cancer diagnostics and for identification of castration-resistant prostate cancer patients

Bioorganic & Medicinal Chemistry ◽

10.1016/j.bmc.2021.116156 ◽

2021 ◽

Vol 39 ◽

pp. 116156

Author(s):

Aniko Bertokova ◽

Tomas Bertok ◽

Eduard Jane ◽

Michal Hires ◽

Petra Ďubjaková ◽

...

Keyword(s):

Prostate Cancer ◽

Cancer Patients ◽

Prostate Specific Antigen ◽

Early Stage ◽

Specific Antigen ◽

Cancer Diagnostics ◽

Castration Resistant Prostate Cancer ◽

Castration Resistant

Download Full-text

Prostatic volume and volume-adjusted prostate-specific antigen as predictive parameters for prostate cancer patients with intermediate PSA levels

Prostate Cancer and Prostatic Diseases ◽

10.1038/sj.pcan.4500957 ◽

2007 ◽

Vol 10 (3) ◽

pp. 274-278 ◽

Cited By ~ 14

Author(s):

N Tanaka ◽

K Fujimoto ◽

Y Chihara ◽

M Torimoto ◽

Y Hirao ◽

...

Keyword(s):

Prostate Cancer ◽

Cancer Patients ◽

Prostate Specific Antigen ◽

Specific Antigen ◽

Prostatic Volume ◽

Predictive Parameters

Download Full-text

Effects of the somatostatin analog lanreotide on the circulating levels of chromogranin-A, prostate-specific antigen, and insulin-like growth factor-1 in advanced prostate cancer patients

The Prostate ◽

10.1002/pros.1064 ◽

2001 ◽

Vol 47 (3) ◽

pp. 205-211 ◽

Cited By ~ 21

Author(s):

Alfredo Berruti ◽

Luigi Dogliotti ◽

Alessandra Mosca ◽

Roberto Tarabuzzi ◽

Mirella Torta ◽

...

Keyword(s):

Prostate Cancer ◽

Growth Factor ◽

Cancer Patients ◽

Prostate Specific Antigen ◽

Chromogranin A ◽

Advanced Prostate Cancer ◽

Specific Antigen ◽

Somatostatin Analog ◽

Insulin Like Growth Factor ◽

Circulating Levels

Download Full-text

Relationship between prostate-specific antigen kinetics and detection rate of radiolabelled choline PET/CT in restaging prostate cancer patients: a meta-analysis

Clinical Chemistry and Laboratory Medicine (CCLM) ◽

10.1515/cclm-2013-0675 ◽

2014 ◽

Vol 52 (5) ◽

Cited By ~ 64

Author(s):

Giorgio Treglia ◽

Luca Ceriani ◽

Ramin Sadeghi ◽

Giampiero Giovacchini ◽

Luca Giovanella

Keyword(s):

Prostate Cancer ◽

Cancer Patients ◽

Prostate Specific Antigen ◽

Detection Rate ◽

Meta Analysis ◽

Specific Antigen ◽

Choline Pet ◽

Pet Ct

Download Full-text

Survival outcomes of Chinese metastatic prostate cancer patients following primary androgen deprivation therapy in relation to prostate-specific antigen nadir level

Asia-Pacific Journal of Clinical Oncology ◽

10.1111/ajco.12313 ◽

2014 ◽

Vol 13 (2) ◽

pp. e65-e71 ◽

Cited By ~ 2

Author(s):

Jeremy Yuen Chun Teoh ◽

James Hok Leung Tsu ◽

Steffi Kar Kei Yuen ◽

Samson Yun Sang Chan ◽

Peter Ka Fung Chiu ◽

...

Keyword(s):

Prostate Cancer ◽

Cancer Patients ◽

Prostate Specific Antigen ◽

Androgen Deprivation Therapy ◽

Metastatic Prostate Cancer ◽

Specific Antigen ◽

Androgen Deprivation ◽

Survival Outcomes ◽

Primary Androgen Deprivation Therapy ◽

Primary Androgen Deprivation

Download Full-text

Classifying prostate cancer patients based on total prostate-specific antigen and free prostate-specific antigen features by support vector machine

Journal of Cancer Research and Therapeutics ◽

10.4103/0973-1482.172133 ◽

2016 ◽

Vol 12 (2) ◽

pp. 818 ◽

Cited By ~ 2

Author(s):

PhamThe Bao ◽

NguyenThi Hong Nhung ◽

VuTran Minh Khuong ◽

VuQuang Huy

Keyword(s):

Prostate Cancer ◽

Support Vector Machine ◽

Cancer Patients ◽

Prostate Specific Antigen ◽

Specific Antigen ◽

Support Vector ◽

Total Prostate Specific Antigen

Download Full-text

Increasing role of prostate specific antigen (PSA) in the clinical staging of prostate cancer patients

European Surgery ◽

10.1007/bf02602013 ◽

1993 ◽

Vol 25 (1) ◽

pp. 4-7

Author(s):

A. M. Sassine ◽

C. Schulman

Keyword(s):

Prostate Cancer ◽

Cancer Patients ◽

Prostate Specific Antigen ◽

Specific Antigen ◽

Clinical Staging

Download Full-text